María Virginia Villegas

Author

Centro Internacional de Entrenamiento e Investigaciones Medicas ORCID

Also Known As

Costa Rica, Francisco Emmanuel Alvarez-Bautista, Jinnethe Reyes, Kenneth S Thomson, M V Villegas, M. V. VILLEGAS, M. V. Villegas, M. Villegas, M.-V. Villegas, M.V. Villegas

202

Publications

16.6K

Citations

H-Index

Concepts

All Affiliations

Centro Internacional de Entrenamiento e Investigaciones Medicas Universidad El Bosque Case Western Reserve University Louis Stokes Cleveland VA Medical Center Inserm

About

María Virginia Villegas is an author at Centro Internacional de Entrenamiento e Investigaciones Medicas specializing in medicine, antimicrobial resistance, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	32	9.4K
2	Health Sciences	18	21	8.1K
3	Engineering	1	1	31
4	Humanities	1	1	11
5	Natural Sciences	1	1	51

María Virginia Villegas

Publications

11.3K

Citations

H-Index

Page 1

	Year	Citations
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis Evelina Tacconelli, Elena Carrara, Alessia Savoldi, The Lancet Infectious Diseases Bacterial ResistanceAntimicrobial Drug DiscoveryAntimicrobial SusceptibilityHealth SciencesAntibiotics	2017	5.8K
Genetic Structures at the Origin of Acquisition of the β-Lactamase <i>bla</i> <sub>KPC</sub> Gene Thierry Naas, Gaëlle Cuzon, María Virginia Villegas, Antimicrobial Agents and Chemotherapy GeneticsKlebsiella PneumoniaeBacteriologyMolecular BiologyMolecular Genetics	2008	519
Acquisition of a natural resistance gene renders a clinical strain of methicillin‐resistant<i>Staphylococcus aureus</i>resistant to the synthetic antibiotic linezolid Seok‐Ming Toh, Liqun Xiong, César A. Arias, Molecular Microbiology Molecular BiologyAntimicrobial ChemotherapyAntibiotic ResistanceBacterial PathogensDrug Resistance	2007	333
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study Minggui Wang, Michelle Earley, Liang Chen, The Lancet Infectious Diseases Different Global RegionsAntimicrobial SusceptibilityHealth SciencesAntibioticsMedicine	2021	308
The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae Laurent Poirel, Aurélie Jayol, Séverine Bontron, Journal of Antimicrobial Chemotherapy	2014	299
Worldwide Diversity of<i>Klebsiella pneumoniae</i>That Produce β-Lactamase<i>bla</i><sub>KPC-2</sub>Gene1 Gaëlle Cuzon, Thierry Naas, H. Tuan Truong, Emerging infectious diseases Antimicrobial Resistance GeneTn4401 IsoformsHealth SciencesAntibioticsDrug Resistance	2010	298
First Identification of <i>Pseudomonas aeruginosa</i> Isolates Producing a KPC-Type Carbapenem-Hydrolyzing β-Lactamase María Virginia Villegas, Karen Lolans, Adriana Correa, Antimicrobial Agents and Chemotherapy First IdentificationBacteriologyAntibiotic ResistanceBacterial PathogensDrug Resistance	2007	292
Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study Jinnethe Reyes, Lauren Komarow, Liang Chen, The Lancet Microbe	2023	255
First Detection of the Plasmid-Mediated Class A Carbapenemase KPC-2 in Clinical Isolates of <i>Klebsiella pneumoniae</i> from South America María Virginia Villegas, Karen Lolans, Adriana Correa, Antimicrobial Agents and Chemotherapy Klebsiella PneumoniaeBacterial PathogensDrug ResistanceMedical MicrobiologySouth America	2006	231
Resistance to Colistin Associated with a Single Amino Acid Change in Protein PmrB among Klebsiella pneumoniae Isolates of Worldwide Origin Aurélie Jayol, Laurent Poirel, Adrian Brink, Antimicrobial Agents and Chemotherapy	2014	229

Page 1